Advances in Cancer Immunotherapy™ 2017 Video Series: Management and Mitigation of irAEs for Immunotherapy Prescribers

aci17-sitc-clr.jpgExemplar video presentations from the live Advances in Cancer Immunotherapy™ (ACI) programs are used as content for online courses. One video has been selected for each topic of the 2017 ACI program (twelve total modules).

 

The online modules will facilitate understanding of the clinical applications of immunotherapy for disease states with FDA-approved treatments; strategies for overcoming operational and reimbursement barriers to implementing immunotherapy in a community setting; and the identification and management of immune-related adverse events.


This course is Module 11 of 12: The Management and Mitigation of irAEs for Immunotherapy Prescribers. This module covers common immune-related adverse events by organ system, rare immune-related toxicities, irAEs associated with combination immunotherapy, the use of corticosteroids and other immunosuppressive agents in the management of irAEs, and indications for continuing or discontinuing immunotherapy. The module also includes case studies on the management of irAEs.

Target Audience

These modules have been designed to meet the educational needs of physicians, pharmacists, registered nurses and other healthcare professionals involved in the care of patients with cancer.

 

Approximate Time to Complete: 30 minutes

 

Credit Availabe: Oct. 6, 2017- September 30, 2018

 

Other Available Modules

Module 1: Basic Principles of Cancer Immunotherapy

Module 2: Immunotherapy for the Treatment of Melanoma

Module 3: Immunotherapy for the Treatment of Lung Cancer

Module 4: Immunotherapy for the Treatment of Genitourinary Cancers

Module 5: Immunotherapy for the Treatment of Hematologic Malignancies

Module 6: Immunotherapy for the Treatment of Head and Neck Cancers

Module 7: Effective Practices for Incorporating Immunotherapy into Hospital Operations 

Module 8: Coverage and Reimbursement Challenges and Strategies

Module 9: Mechanisms of Immune-Related Adverse Events

Module 10: Nursing Perspective on irAEs: Patient Education, Monitoring and Management 

Module 11: Management and Mitigation of irAEs for Immunotherapy Prescribers 

Module 12: Identification and Management of Immune-Related Adverse Events in the Emergency Setting

Course Objectives
Upon completion of this activity, participants will be able to:
  • Describe the rationale for common approaches to cancer immunotherapy.
  • Identify the appropriate clinical management of common side effects of immunotherapy agents.
  • Implement cancer immunotherapy treatments for melanoma, lung, genitourinary, head and neck, and/or hematologic cancers into clinical practice appropriately.
  • Provide appropriate care and counsel for patients receiving immunotherapy and their families.
  • Pharmacist participants will be able to provide accurate and appropriate counsel as part of the treatment team.
Register Now
In order to access this program after registering, a SITC account will be provided for you based on the information you have entered.

To access your account after your purchase, use the My Account links on the left hand side of this page to login using the information your provide here.
According to our records there is already a SITC account using the email address you have provided.

To continue with your registration please enter your account password. If you do not know your account password you can retrieve it here: Forgot Password?
First Name:
Last Name:
Email:
Confirm Email:
Which degree best describes you? :
Other degree, please describe:
What is your professional role? (If more than one applies to you, type additional roles below):
Other professional role, please describe:
If more than one professional role applies to you, please enter the additional roles here:
Which of the following best describes your primary work setting? :
Other primary work setting, please describe: :
What is your area of specialization?:
Other area of specialization, please describe::
Product:
Advances in Cancer Immunotherapy (TM) 2017 Video Series: Management and Mitigation of irAEs
The email address you have entered has an existing SITC account.

Please enter your password in the field below. Forgot Password?

Email:
Password:
Country:
Billing Address:
City:
State:
State/Province:
Zip:
Expiration: 
Pre-Test: Management and Mitigation of irAEs for Immunotherapy Prescribers

Before beginning the presentation, please complete the brief pre-test questions.

Advances in Cancer Immunotherapy™ 2017: Management and Mitigation of irAEs for Immunotherapy Prescribers

It is important to note there are twelve ACI online modules, you are currently reviewing module eleven.


The Management and Mitigation of irAEs for Immunotherapy Prescribers module covers common immune-related adverse events by organ system, rare immune-related toxicities, irAEs associated with combination immunotherapy, the use of corticosteroids and other immunosuppressive agents in the management of irAEs, and indications for continuing or discontinuing immunotherapy. The module also includes case studies on the management of irAEs.

Speaker Information
Ronny Mario Otero, MD, FAAEM  [ view bio ]
Individual topic purchase: Selected